Clinical Trials Browser

OTHER × Interventional × Splenomegaly × Clear all

NCT07379125 2026-01-30

Therapeutic RSK1 Targeting in Myelofibrosis

Phase 1 Not yet recruiting

Classical hematologyMyeloid

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Splenomegaly, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT03895112 2023-02-10

MPN-RC 118 AVID200 in Myelofibrosis

Phase 1 Completed

Fibrosis, Splenomegaly, Primary Myelofibrosis

NCT04716166 2021-10-20

Incentive Spirometry and Upper Abdominal Laparoscopic Surgery

Phase NA Completed

Gastrointestinal

Cholecystitis, Hernia, Diaphragmatic, Hernia, Hiatal, Pancreatic Neoplasms, Splenic Infarction, Splenomegaly, Choledocholithiasis

NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Phase 1 Completed

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04524676 2020-08-24

Oxaliplatin-induced Portal Hypertension

Phase NA Unknown

Gastrointestinal

Hypertension, Portal, Splenomegaly, Colorectal Neoplasms

NCT02730884 2020-08-07

Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia

Phase 2 Terminated

3 enrolled 6 charts

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Splenomegaly, Primary Myelofibrosis

NCT02421354 2019-05-15

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

Phase 2 Terminated

8 enrolled 7 charts

Hepatomegaly, Polycythemia Vera, Splenomegaly, Primary Myelofibrosis